Syneos Health

Pharma media teams have plenty of data. The challenge is turning it into better investment decisions. I joined Oliver Matthews from causaLens to discuss how AI can help teams move beyond reporting what happened to deciding what to do next, and from sharpening targeting to improving spend efficiency. For me, adoption comes down to trust, explainability and workflows that fit how people work. Human judgment remains essential. Watch our conversation, “Beyond Attribution: Using AI to Improve Media Investment Decisions”: https://lnkd.in/gvb3kTtk #AI #AgenticAI #Pharma #MediaStrategy #SyneosHealth

An open sales territory costs more than the time it takes to hire a replacement. Prescriber relationships lose momentum, coverage slips and neighboring reps take on more work.That’s why I believe vacancy coverage deserves the same planning and accountability as any other commercial priority.A contract sales organization can help maintain continuity while permanent hiring continues, with clear expectations for deployment, performance and quality. The operating structure matters just as much as the talent.In my latest Syneos Health Insights Hub paper, “Closing the Vacancy Gap,” I explore how to build that model and what commercial leaders should ask of a deployment partner.Read the paper: Closing the Vacancy Gap: https://lnkd.in/esSV_gW4 #Pharma #CommercialStrategy #SalesEffectivenes

AI is changing how stakeholders encounter and understand brands. And that raises an important question: If AI had to explain your brand first, would it say what you intended? In my latest blog, I explore why brand coherence matters more than ever as AI increasingly reads, interprets and compresses information across the content we put into the world. For biopharmaceutical brands, the opportunity is to build a clear, distinctive and consistent identity early, giving both people and AI stronger signals about who you are, what you stand for and why you matter. Read more on why clarity wins under compression: https://lnkd.in/guBy_fsg #ArtificialIntelligence #Biopharma #HealthcareCommunications #AI #SyneosHealth

Really enjoyed this conversation with Dale F. Lippert Sr., RN, BS, MS on our Conversations on Commercialization podcast. We dug into what it really takes to reduce friction across the CAR T patient journey, from improving coordination and reducing delays to building patient support models that can scale without losing sight of the patient and caregiver experience. Dale brings decades of experience launching CAR T therapies and shared some great practical insights on what works, where challenges arise and why speed and communication matter so much in this space. Give the episode a listen: Reducing Friction in CAR T Care: Patient Support for Speed, Scale and Better Outcomes. https://lnkd.in/gJW_z7pX #CART #PatientSupport #CellTherapy #Commercialization #SyneosHealth

Trust and influence are no longer the same thing. That may be one of the most important shifts facing healthcare communicators. People still trust physicians and traditional sources of expertise. But their first impressions, questions, and beliefs are increasingly shaped by emerging media, creators, online communities, podcasts, AI tools, peers, and social platforms , often before they ever speak to a physician. Syneos Health Communications partnered with The Harris Poll to survey more than 1,500 U.S. consumers and 200 primary care physicians on how emerging media is reshaping health opinion, trust, and decision-making. For communicators, the implication is clear: we need to understand not only who audiences trust, but who helps them make sense of complex health information. Explore the research and download the full findings: link to the findings are in my comment below. #HealthcareCommunications #HealthCommunications #Biopharma #EmergingMedia #SyneosHealth

Bring your CRA expertise to studies that matter. Work alongside industry-leading teams and help accelerate the development of life-changing therapies.